1. Home
  2. MRUS vs LSTR Comparison

MRUS vs LSTR Comparison

Compare MRUS & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • LSTR
  • Stock Information
  • Founded
  • MRUS 2003
  • LSTR 1991
  • Country
  • MRUS Netherlands
  • LSTR United States
  • Employees
  • MRUS N/A
  • LSTR N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • LSTR Trucking Freight/Courier Services
  • Sector
  • MRUS Health Care
  • LSTR Industrials
  • Exchange
  • MRUS Nasdaq
  • LSTR Nasdaq
  • Market Cap
  • MRUS 4.1B
  • LSTR 4.6B
  • IPO Year
  • MRUS 2016
  • LSTR 1993
  • Fundamental
  • Price
  • MRUS $67.47
  • LSTR $132.08
  • Analyst Decision
  • MRUS Strong Buy
  • LSTR Hold
  • Analyst Count
  • MRUS 13
  • LSTR 14
  • Target Price
  • MRUS $90.92
  • LSTR $148.42
  • AVG Volume (30 Days)
  • MRUS 550.9K
  • LSTR 337.1K
  • Earning Date
  • MRUS 10-30-2025
  • LSTR 10-28-2025
  • Dividend Yield
  • MRUS N/A
  • LSTR 2.72%
  • EPS Growth
  • MRUS N/A
  • LSTR N/A
  • EPS
  • MRUS N/A
  • LSTR 4.77
  • Revenue
  • MRUS $56,228,000.00
  • LSTR $4,802,153,000.00
  • Revenue This Year
  • MRUS $57.42
  • LSTR $1.38
  • Revenue Next Year
  • MRUS $0.23
  • LSTR $8.10
  • P/E Ratio
  • MRUS N/A
  • LSTR $27.77
  • Revenue Growth
  • MRUS 59.77
  • LSTR N/A
  • 52 Week Low
  • MRUS $33.19
  • LSTR $123.43
  • 52 Week High
  • MRUS $69.20
  • LSTR $196.86
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 58.81
  • LSTR 48.70
  • Support Level
  • MRUS $62.80
  • LSTR $129.01
  • Resistance Level
  • MRUS $67.84
  • LSTR $134.23
  • Average True Range (ATR)
  • MRUS 2.39
  • LSTR 3.43
  • MACD
  • MRUS -0.22
  • LSTR 0.43
  • Stochastic Oscillator
  • MRUS 73.67
  • LSTR 46.81

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

Share on Social Networks: